DE-ENIGMA · Project

Robot-Assisted Therapy Platform That Teaches Social Skills to Autistic Children

healthTestedTRL 5

Imagine a friendly robot that helps autistic children learn to read emotions and express their feelings — like a patient, predictable practice partner that never gets frustrated. Kids with autism often find human faces overwhelming and unpredictable, but they feel comfortable with robots. This project built a smart robot system that can read a child's facial expressions, body language, and voice, then adapt its teaching style to each individual child and their cultural background. Parents and therapists also get a dashboard to track progress and share experiences.

By the numbers

5 million

People with autism in Europe

1 in 100

Autism prevalence rate in Europe

20 million+

People affected by autism daily in Europe

Consortium partners

Countries in the consortium

Total project deliverables

The business problem

What needed solving

Autism affects 1 in 100 people in Europe — over 5 million individuals — and existing social skills therapy is expensive, hard to scale, and depends heavily on individual therapist availability. Children with autism often find human interaction overwhelming, making traditional therapy sessions less effective. There is a growing gap between the number of children who need social skills training and the capacity of therapy centers to deliver it.

The solution

What was built

The project built a multimodal robot interaction system that reads children's facial expressions, body language, voice, and speech to deliver personalized social skills therapy. Concrete outputs include a freely available battery of validated behavioral tasks for measuring socioemotional cue perception and expression, plus a supportive environment for caregivers with progress reports and community forums — 19 deliverables in total.

Audience

Who needs this

Pediatric autism therapy centers looking for scalable intervention toolsEdTech companies developing special needs learning productsSocial robotics manufacturers seeking healthcare applicationsNational health services planning autism support programsInsurance companies evaluating cost-effective autism interventions

Business applications

Who can put this to work

Pediatric therapy and rehabilitation centers

SME

Target: Clinics and therapy centers specializing in autism spectrum conditions

If you are a pediatric therapy center struggling to engage autistic children in social skills training — this project developed a robot-based interaction system that adapts to each child's responses using facial, bodily, vocal and verbal cues. With over 5 million people with autism in Europe (1 in 100), demand for effective therapy tools is growing. The system includes validated behavioral tasks and progress tracking for therapists.

Educational technology

mid-size

Target: Companies developing assistive learning tools for special education

If you are an edtech company looking to expand into special needs education — this project created a multimodal human-robot interaction platform tested across 7 countries with children with autism. The validated behavioral task battery is designed to measure perception, recognition, understanding and expression of socioemotional cues. This gives you a research-backed foundation for a commercial product serving a market that affects over 20 million people in Europe.

Social robotics and assistive devices

any

Target: Robotics companies building companion or therapy robots

If you are a robotics manufacturer looking to enter the healthcare-assistive market — this project solved key technical challenges in making robots context-sensitive, culture-aware, and user-adaptive for vulnerable populations. The 9-partner consortium across 7 countries validated the approach with real clinical settings. Their freely available behavioral task battery and 19 deliverables offer a ready integration path for your robot platform.

Frequently asked

Quick answers

What would it cost to license or adopt this technology?

The project made its battery of validated behavioral tasks freely available to researchers via its website. Commercial licensing terms for the full robot interaction system are not specified in the project data — you would need to contact the coordinator at Universiteit Twente to discuss terms.

Can this scale to serve therapy centers across multiple countries?

The system was explicitly designed to be culture-specific and was developed and tested across a 7-country consortium (BE, DE, NL, PT, RO, RS, UK). This multi-cultural validation suggests it can adapt to different European markets. With over 5 million autistic individuals in Europe, the addressable market is substantial.

Who owns the intellectual property?

The project was funded as a Research and Innovation Action (RIA), coordinated by Universiteit Twente. The behavioral task battery is freely available, but the core robot interaction technology IP likely resides with the consortium partners. Contact the coordinator for licensing discussions.

Does this comply with healthcare and data privacy regulations?

The project involved children with autism, which means it operated under strict ethical oversight during EU funding. However, any commercial deployment would need to meet current medical device regulations and GDPR requirements for processing children's data, including facial and vocal analysis.

How long before this could be deployed in a real clinic?

The project ran from 2016 to 2019 and produced 19 deliverables including validated behavioral tasks. The technology reached a tested stage with real users. Moving to commercial deployment would require productization, regulatory clearance, and integration with existing therapy workflows.

Can this integrate with existing therapy tools and robot platforms?

The system was designed for multimodal interaction including facial, bodily, vocal and verbal cues. Based on available project data, the behavioral task battery is portable and freely downloadable. Integration with specific robot hardware would depend on the platform's sensor capabilities.

Consortium

Who built it

The DE-ENIGMA consortium brings together 9 partners from 7 countries, but is heavily research-oriented: 5 universities, 1 research organization, and only 1 industry partner (with 1 SME). The 11% industry ratio means this technology was developed primarily in academic settings. For a business looking to commercialize, this is both a risk and an opportunity — the science is strong and peer-validated across multiple countries, but turning it into a market-ready product will require significant commercial partnership and productization effort. Universiteit Twente in the Netherlands leads the project and would be your entry point.

UNIVERSITEIT TWENTECoordinator · NL
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINEparticipant · UK
IDMIND - ENGENHARIA DE SISTEMAS LDAparticipant · PT
AUTISME-EUROPE AISBLparticipant · BE
UNIVERSITAET AUGSBURGparticipant · DE
UNIVERSITY COLLEGE LONDONparticipant · UK
UNIVERSITAT PASSAUparticipant · DE

How to reach the team

Universiteit Twente, Netherlands — contact via university research office or project website

Order a report on this consortium See UNIVERSITEIT TWENTE profile →

Next steps

Talk to the team behind this work.

Want an introduction to the DE-ENIGMA research team? SciTransfer can connect you with the right people and provide a detailed technology brief tailored to your business needs.

Order a report on this topic More in Health & Biomedical